CS27109, A Selective Thyroid Hormone Receptor-β Agonist Alleviates Metabolic-Associated Fatty Liver Disease in Murine Models

Figure 4

CS27109 mitigates steatohepatitis and hepatic fibrosis in WD + CCL4 mouse model: (a) H and E and sirius red staining of livers among different treating groups after 4-week drug intervention for determining steatohepatitis and fibrosis, respectively, (b) steatosis, (c) inflammation, (d) ballooning (e) NAS score, and (f) fibrosis area of liver pathology among different groups. and ^# represents normal vs. model and drugs vs. model, respectively. , , , , , , and .

(a)

(b)

(c)

(d)

(e)

(f)